ResMed Inc. (RMD)
NYSE · Healthcare
ResMed Inc. Income Statement 2009–2025
| Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2011 | Jun 2010 | Jun 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||||
| Revenue | 5.15B | 4.69B | 4.22B | 3.58B | 3.20B | 2.96B | 2.61B | 2.34B | 2.07B | 1.84B | 1.68B | 1.55B | 1.51B | 1.37B | 1.24B | 1.09B | 920.7M |
| Gross Profit | 3.05B | 2.66B | 2.36B | 2.02B | 1.84B | 1.72B | 1.49B | 1.33B | 1.20B | 1.07B | 1.01B | 989.8M | 940.7M | 820.7M | 741.3M | 655.5M | 553.8M |
| Profitability | |||||||||||||||||
| Operating Income | 1.69B | 1.32B | 1.13B | 1.00B | 903.7M | 809.7M | 579.3M | 541.8M | 425.8M | 429.0M | 409.2M | 405.1M | 354.8M | 294.4M | 266.9M | 240.4M | 190.3M |
| EBITDA | 1.88B | 1.50B | 1.30B | 1.16B | 1.06B | 964.5M | 730.1M | 661.8M | 538.0M | 515.8M | 482.3M | 478.5M | 433.1M | 380.3M | 337.5M | 301.9M | 244.3M |
| Net Income | 1.40B | 1.02B | 897.6M | 779.4M | 474.5M | 621.7M | 404.6M | 315.6M | 342.3M | 352.4M | 352.9M | 345.3M | 307.1M | 254.8M | 227.0M | 190.1M | 146.4M |
| Per Share Data | |||||||||||||||||
| EPS (diluted) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 147M | 148M | 147M | 147M | 146M | 146M | 144M | 144M | 142M | 142M | 143M | 144M | 146M | 149M | 157M | 155M | 154M |
ResMed Inc. Income Statement — FAQ
ResMed Inc. (RMD) income statement over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see RMD's income statement history?
The chart and table above show ResMed Inc.'s income statement by year and by quarter, including the growth rate.